Chapter 8. Adjuvant Radiotherapy and Chemoradiotherapy in the Treatment of Rectal Cancer
- John H. Scholefield1,
- Axel Grothey2,
- Herand Abcarian3,
- Tim Maughan4
Published Online: 14 JAN 2008
DOI: 10.1002/9780470753231.ch8
Copyright © 2006 by Blackwell Publishing Ltd
Book Title

Challenges in Colorectal Cancer
Additional Information
How to Cite
Cooper, R. and Sebag-Montefiore, D. (2008) Adjuvant Radiotherapy and Chemoradiotherapy in the Treatment of Rectal Cancer, in Challenges in Colorectal Cancer (eds J. H. Scholefield, A. Grothey, H. Abcarian and T. Maughan), Blackwell Publishing Ltd, Malden, Massachusetts, USA. doi: 10.1002/9780470753231.ch8
Editor Information
- 1
Professor of Surgery, University Hospital, Nottingham, UK
- 2
Professor, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA
- 3
Turi Josefsen Professor and Chairman, Department of Surgery, University of Illinois College of Medicine, Chicago, Illinois, USA
- 4
Professor of Cancer Studies, University of Cardiff, Cardiff, UK
Publication History
- Published Online: 14 JAN 2008
- Published Print: 1 JAN 2006
ISBN Information
Print ISBN: 9781405127066
Online ISBN: 9780470753231
- Summary
- Chapter
- References
Keywords:
- radiotherapy;
- chemoradiotherapy;
- rectal cancer;
- surgery;
- adhesions
Summary
This chapter contains section titled:
Introduction
What is the evidence base for adjuvant radiotherapy?
What is the benefit of adjuvant radiotherapy in addition to total mesorectal excision surgery?
Is preoperative radiotherapy superior to postoperative radiotherapy?
What is the benefit of the addition of chemotherapy to long-course radiotherapy?
What is the evidence for the role of pelvic MRI in preoperative staging?
What are the late effects of adjuvant radiotherapy?
Why do international differences in selection policy in patients with resectable rectal cancer persist?
Preoperative chemoradiotherapy for locally advanced rectal cancer
Can adjuvant treatment achieve sphincter preservation?
Conclusion
